Published in Biochem J on January 15, 1993
Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature (2011) 2.82
Identification of Ser/Thr phosphorylation sites in the C2-domain of phospholipase C γ2 (PLCγ2) using TRPM7-kinase. Cell Signal (2012) 0.92
Does a higher ratio of serum calcium to magnesium increase the risk for postmenopausal breast cancer? Med Hypotheses (2010) 0.86
Molecular characterization and subcellular localization of Arabidopsis class VIII myosin, ATM1. J Biol Chem (2014) 0.83
Divalent cation signaling in immune cells. Trends Immunol (2014) 0.80
Immunology: Magnesium in a signalling role. Nature (2011) 0.79
Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature (1984) 25.71
The inositol trisphosphate phosphomonoesterase of the human erythrocyte membrane. Biochem J (1982) 6.82
The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell (1991) 6.13
Turnover of inositol phospholipids and signal transduction. Science (1984) 5.76
Cytoplasmic pH and free Mg2+ in lymphocytes. J Cell Biol (1982) 5.30
Association of B cell antigen receptor with protein tyrosine kinase Lyn. Science (1991) 3.86
Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry. J Immunol (1986) 3.08
The B-cell antigen receptor complex. Immunol Today (1991) 1.74
Characterization of D-myo-inositol 1,4,5-trisphosphate phosphatase in rat liver plasma membranes. J Biol Chem (1984) 1.70
T-lymphocyte activation: the role of protein kinase C and the bifurcating inositol phospholipid signal transduction pathway. Immunol Rev (1987) 1.60
Transmembrane signals and intracellular "second messengers" in the regulation of quiescent B-lymphocyte activation. Immunol Rev (1987) 1.32
Monitoring cytosolic free magnesium in cultured chicken heart cells by use of the fluorescent indicator Furaptra. Proc Natl Acad Sci U S A (1989) 1.28
Regulation of inositol 1,4,5-trisphosphate kinase activity after stimulation of human T cell antigen receptor. J Clin Invest (1987) 1.18
Requirement of Ca2+ for the production and degradation of inositol 1,4,5-trisphosphate in macrophages. Biochim Biophys Acta (1986) 1.08
Divalent cation regulation of phosphoinositide metabolism. Naturally occurring B lymphoblasts contain a Mg2(+)-regulated phosphatidylinositol-specific phospholipase C. J Biol Chem (1990) 0.94
The bivalent-cation dependence of phosphatidylinositol synthesis in a cell-free system from lymphocytes. Biochem J (1983) 0.89
ADP requirement for prevention by a cytosolic factor of Mg2+ and Ca2+ release from rat liver mitochondria. Arch Biochem Biophys (1974) 0.88
Improved method for measuring intracellular Ca++ with fluo-3. Cytometry (1990) 0.86
INCA: software for consort 30 analysis of flow cytometric calcium determinations. Cytometry (1989) 0.82
Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density. Microvasc Res (2000) 1.67
Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1. Oncogene (2012) 1.37
Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res (2000) 1.34
Entorhinal projections to the hippocampal CA1 region in the rat: an underestimated pathway. Neurosci Lett (1988) 1.24
Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes. J Biol Chem (1996) 1.14
Anti-capsular polysaccharide antibody deficiency states. Immunodeficiency (1993) 1.12
Tumor angiogenesis factors reduce leukocyte adhesion in vivo. Int Immunol (2000) 0.98
Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Mol Hum Reprod (2006) 0.96
A new role for NF-kappaB in angiogenesis inhibition. Cell Death Differ (2007) 0.95
Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers. Cell Death Dis (2012) 0.95
Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma. Oncogene (2010) 0.93
Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. Blood (2000) 0.93
Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors. Br J Cancer (2011) 0.92
Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment. Br J Cancer (2002) 0.92
Ligation of membrane immunoglobulin leads to inactivation of the signal-transducing ability of membrane immunoglobulin, CD19, CD21, and B-cell gp95. Proc Natl Acad Sci U S A (1990) 0.92
Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors. Cancer Lett (1997) 0.92
Dynamic contrast-enhanced magnetic resonance imaging at 1.5 Tesla with gadopentetate dimeglumine to assess the angiostatic effects of anginex in mice. Eur J Cancer (2004) 0.90
In vitro tumor angiogenesis assays: plasminogen lysine binding site 1 inhibits in vitro tumor-induced angiogenesis. J Vasc Res (1998) 0.89
High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. Br J Cancer (2007) 0.89
Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells. Angiogenesis (2001) 0.88
Angiogenic potential of malignant and non-malignant human breast tissues in an in vivo angiogenesis model. Int J Cancer (1998) 0.87
Improved method for measuring intracellular Ca++ with fluo-3. Cytometry (1990) 0.86
Effect of culture conditions on endothelial cell growth and responsiveness. Tissue Cell (1998) 0.86
Angiostatic proteins and peptides. Crit Rev Eukaryot Gene Expr (2001) 0.85
Endothelial cell anergy is mediated by bFGF through the sustained activation of p38-MAPK and NF-kappaB inhibition. Int J Immunopathol Pharmacol (2006) 0.84
INCA: software for consort 30 analysis of flow cytometric calcium determinations. Cytometry (1989) 0.82
Rocking the foundations of solid tumor growth by attacking the tumor's blood supply. Immunol Today (1998) 0.81
CD44 splice variants; expression on lymphocytes and in neoplasia. Res Immunol (1994) 0.81
[Angiogenesis and the regulation of antitumor defense]. Ned Tijdschr Geneeskd (1999) 0.78
In vivo antitumour effect of combretastatin A-4 phosphate added to fractionated irradiation. Anticancer Res (2006) 0.78
Abnormal signal transduction in a patient with severe combined immunodeficiency disease. Pediatr Res (1991) 0.78
Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cells. J Immunol (1992) 0.77
Endoglin/CD 105 may not be an optimal tumor endothelial treatment target. Breast Cancer Res Treat (1996) 0.76
Immunoregulation in man. Neth J Med (1991) 0.76
T cell function in patients with impaired antibody responses to polysaccharide antigens. Eur J Immunol (1991) 0.75
Evidence that FMC7 is a human B cell differentiation antigen. Immunol Lett (1990) 0.75
Intracellular magnesium movements and lymphocyte activation. Magnes Res (1993) 0.75